AbbVie's Ludwigshafen facility is situated in the heart of the Rhine Neckar biotechnology region in Western Central Germany, approximately 60 miles south of Frankfurt. The site has been in operation since 1886, and continues to thrive as a center of excellence for drug product research, development and manufacturing.
AbbVie’s German pharmaceutical manufacturers specialize in innovative solutions for solid dosage forms, including cutting-edge hot melt extrusion capabilities to offer solutions to challenging API formulation. This unique resource can help small-, mid-, and large-scale pharmaceutical companies worldwide access leading drug formulation technologies and expertise.
AbbVie is committed to meeting environmental rules and policies relevant to pharmaceutical manufacturers in Germany and beyond.
AbbVie's has a network of manufacturing facilities around the world to support your project and project needs. See AbbVie's other locations for additional manufacturing site information and technical expertise.
AbbVie’s Ludwigshafen facility offers specialized services that center around the enhancement of existing APIs. Our continuous processing capabilities provide a more economical manufacturing pathway for poorly-soluble or potent API’s. With focused technology and personnel, our leading German pharmaceutical manufacturer also offers abuse deterrence, taste masking, and solvent-free formulations.
AbbVie’s Ludwigshafen contract manufacturing expertise:
To discuss how these technologies can benefit your drug development program, contact AbbVie today.
AbbVie maintains a range of regional and global regulatory standards to meet guidelines enforced in your country of origin, and those of your intended markets.